Seattle Genetics is a American stock, trading under the symbol SGEN-Q on the NASDAQ (SGEN). It is usually referred to as NASDAQ:SGEN or SGEN-Q
In the last year, there was no coverage of Seattle Genetics published on Stockchase.
Seattle Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Seattle Genetics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Seattle Genetics In the last year. It is a trending stock that is worth watching.
On 2023-12-13, Seattle Genetics (SGEN-Q) stock closed at a price of $228.86.
They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.